Disease-specific therapy for the treatment of the cardiovascular manifestations of Fabry disease: a systematic review

Conclusion
It remains unclear whether disease-specific therapy sufficiently impacts the cardiovascular manifestations of Fabry disease. Further work, ideally in larger cohorts, with more standardised clinical and phenotypic outcomes, the latter measured using contemporary techniques, are required to fully elucidate the cardiovascular impact of disease-specific therapy.

PROSPERO registration number
CRD42022295989.

Source: Heart - December 15, 2023 Category: Cardiology Authors: Orsborne, C., Black, N., Naish, J. H., Woolfson, P., Reid, A. B., Schmitt, M., Jovanovic, A., Miller, C. A. Tags: Open access Systematic review Source Type: research